Healthcare Supply Chain Management Market by Offering (Suite, Analytics, RFID), Function (Procurement, Sourcing, Order Management, Warehouse, Transportation), Managed (Vaccines, CGT), End User (Medical Devices, Pharma), and Region - Global Forecast to 2031
The global healthcare supply chain management market is projected to reach USD 5.31 billion by 2031 from USD 4.13 billion in 2026, at a CAGR of 5.1% during the forecast period. Growing demand for supply chain transparency and traceability is driving adoption of healthcare supply chain management solutions as organizations seek greater visibility into the movement, availability, and status of medical products across the supply chain. Complex supplier networks, increasing product volumes, and the need to ensure product quality and authenticity are encouraging healthcare organizations to strengthen tracking and data-sharing capabilities. Supply chain management solutions enable organizations to monitor procurement, inventory, warehousing, distribution, and product movement, providing greater visibility across supply chain activities. Technologies such as RFID, barcode systems, cloud-based platforms, and real-time analytics further support product tracking and information exchange, helping organizations improve inventory accuracy, identify supply disruptions, strengthen compliance, and reduce the risk of product loss, diversion, or counterfeiting.
The breakdown of primary participants is as mentioned below:
“By product managed, the pharmaceutical and biotechnology segment accounted for the largest share of the healthcare supply chain management market in 2025.”
Based on product managed, the healthcare supply chain management market is segmented into pharmaceutical and biotechnology, medical device and equipment, and other products managed. The pharmaceutical and biotechnology segment accounted for the largest share of the market in 2025, driven by the complex nature of pharmaceutical supply chains and the need to efficiently manage procurement, inventory, warehousing, distribution, and product tracking. Supply chain management solutions help pharmaceutical and biotechnology companies improve demand forecasting, optimize inventory levels, coordinate suppliers, and maintain visibility across product flows. The need for product traceability, regulatory compliance, inventory control, and timely availability of medicines and biologics further supports adoption. Increasing pharmaceutical and biotechnology production and the growing focus on supply chain resilience are also contributing to the segment's leading position.“By deployment model, the cloud-based model is expected to register the fastest growth in the healthcare supply chain management market during the forecast period.”
Based on deployment model, the healthcare supply chain management market is segmented into on-premises model and cloud-based model. The cloud-based model is expected to register the fastest growth during the forecast period, supported by the increasing adoption of scalable and flexible supply chain technologies across healthcare organizations. Cloud-based solutions enable organizations to access supply chain data and applications across locations while supporting real-time visibility, collaboration, analytics, and integration with other enterprise systems. They can also reduce the need for extensive on-site IT infrastructure and facilitate faster deployment and system updates. The growing adoption of AI-enabled analytics, digital procurement, automated inventory management, and connected supply chain platforms is further supporting the shift toward cloud-based deployment.“By region, North America accounted for the largest share of the healthcare supply chain management market in 2025.”
Based on region, the healthcare supply chain management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2025, supported by its established healthcare infrastructure, high healthcare expenditure, presence of major pharmaceutical and medical device companies, and strong adoption of digital supply chain technologies. Healthcare organizations in the region increasingly use supply chain management solutions to improve procurement, inventory optimization, supply chain visibility, and operational efficiency. Established healthcare supply chain technology providers and a growing emphasis on cost optimization, product traceability, and supply chain resilience further support market adoption.The breakdown of primary participants is as mentioned below:
- By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation - Directors: 30%, Managers: 34%, and Others: 36%
- By Region - North America: 40%, Asia Pacific: 20%, Europe: 28%, Latin America: 7%, and Middle East & Africa: 5%
- SAP SE (Germany) and Oracle (US) are key players in the healthcare supply chain management market.
- The study includes an in-depth competitive analysis of these key players in the healthcare supply chain management market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The report analyzes the healthcare supply chain management market and aims to estimate the market size and future growth potential of various market segments, based on offering, function, product managed, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates market opportunities and challenges for stakeholders. The report also examines micro markets in terms of growth trends, prospects, and contributions to the total healthcare supply chain management market. The report forecasts revenue for the market segments across five major regions. The report also provides a competitive analysis of key players in this market, including company profiles, product offerings, recent developments, and key market strategies.Reasons to Buy the Report
This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain a greater share of the market. Firms purchasing the report could use one or a combination of the strategies below to strengthen their market position.This report provides insights on
- Analysis of key drivers (increasing pressure on healthcare providers to improve operational efficiency and profitability, rising demand for healthcare services due to population growth and aging demographics, focus on reducing supply chain costs, demand for transparency and traceability, availability of funding, investments, and partnerships, large-scale drug counterfeiting in pharmaceutical industry), restraints (high implementation costs for advanced technologies, data security and privacy concerns, supply chain disruptions due to global events or geopolitical tensions), opportunities (increasing use of AI-powered solutions, expansion into emerging markets with growing healthcare demands, enhanced focus on sustainability and eco-friendly practices in healthcare logistics), challenges (complex and varying regulatory requirements across regions, shortage of skilled professionals to manage sophisticated systems) are factors contributing the growth of the healthcare supply chain management market.
- Product Development/Innovation: Detailed insights into upcoming trends, research & development activities, and new software launches in the healthcare supply chain management market.
- Market Development: Comprehensive information on the lucrative emerging markets, solution type, component, function, industry, and region.
- Market Diversification: Exhaustive information about the offering portfolios, growing geographies, recent developments, and investments in the healthcare supply chain management market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players: SAP SE (Germany), Oracle (US), IBM (US), Cardinal Health (US), and Infor (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW
3.2 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING AND COUNTRY
3.3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing pressure on healthcare providers to improve operational efficiency and profitability
4.2.1.2 Rising demand for healthcare services due to population growth and aging demographics
4.2.1.3 Focus on reducing supply chain costs
4.2.1.4 Demand for transparency and traceability
4.2.1.5 Availability of funding, investments, and partnerships
4.2.1.6 Large-scale drug counterfeiting in pharmaceutical industry
4.2.2 RESTRAINTS
4.2.2.1 High implementation costs for advanced technologies
4.2.2.2 Data security and privacy concerns
4.2.2.3 Supply chain disruptions due to global events or geopolitical tensions
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing use of AI-powered solutions
4.2.3.2 Expansion into emerging markets with growing healthcare demands
4.2.3.3 Enhanced focus on sustainability and eco-friendly practices in healthcare logistics
4.2.4 CHALLENGES
4.2.4.1 Complex and varying regulatory requirements across regions
4.2.4.2 Shortage of skilled professionals to manage sophisticated systems
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER'S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 THREAT OF NEW ENTRANTS
5.1.5 BARGAINING POWER OF SUPPLIERS
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 TECHNOLOGY INFRASTRUCTURE
5.3.3 PLATFORM DEVELOPMENT
5.3.4 DISTRIBUTION
5.3.5 MARKETING & SALES
5.3.6 POST-SALES SERVICES
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE PRICE OF HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY OFFERING (2025)
5.5.2 INDICATIVE PRICE FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY REGION (2025)
5.6 KEY CONFERENCES & EVENTS, 2026–2027
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 CASE STUDY ANALYSIS
5.10 IMPACT OF US TARIFF OVERVIEW
5.10.1 INTRODUCTION
5.10.2 KEY TARIFF RATES
5.10.3 PRICE IMPACT ANALYSIS
5.10.4 IMPACT ON COUNTRY/REGION
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia Pacific
5.10.5 IMPACT ON END USERS
5.10.5.1 Manufacturers
5.10.5.2 Distributors
5.10.5.3 Healthcare providers
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 BLOCKCHAIN
6.1.2 ARTIFICIAL INTELLIGENCE & MACHINE LEARNING
6.1.3 CLOUD COMPUTING
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 DATA ANALYTICS
6.2.2 INTERNET OF THINGS
6.3 ADJACENT TECHNOLOGIES
6.3.1 AR/VR
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
6.5.1 PATENT PUBLICATION TRENDS
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 AI-ASSISTED PROCUREMENT AND PREDICTIVE INVENTORY MANAGEMENT
6.6.2 REAL-TIME SUPPLY CHAIN VISIBILITY AND INTELLIGENT AUTOMATION
6.6.3 PREDICTIVE SUPPLY CHAIN RISK MANAGEMENT AND RESILIENCE
6.7 IMPACT OF AI/GEN AI IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
6.7.1 KEY USE CASES
6.7.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
6.7.2.1 Case Study 1: Enhancing supply chain with AI Solutions at NHS Blood and Transplant
6.7.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
6.7.3.1 Case Study 2: Leveraging AI for Proactive Infection Prevention in Hospital
6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEM
6.7.4.1 Healthcare IT ecosystem
6.7.4.2 Supply chain management market
6.7.4.3 Cloud ERP market
6.7.5 USERS READINESS AND IMPACT ASSESSMENT
6.7.5.1 User readiness
6.7.5.1.1 User A: Manufacturers
6.7.5.1.2 User B: Distributors
6.7.5.1.3 User C: Providers
6.7.5.2 Impact assessment
6.7.5.2.1 User A: Manufacturers
6.7.5.2.1.1 Implementation
6.7.5.2.1.2 Impact
6.7.5.2.2 User B: Distributors
6.7.5.2.2.1 Implementation
6.7.5.2.2.2 Impact
6.7.5.2.3 User C: Providers
6.7.5.2.3.1 Implementation
6.7.5.2.3.2 Impact
7 REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Middle East & Africa
7.1.2.5 Latin America
7.1.3 INDUSTRY STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.4 KEY STAKEHOLDERS IN BUYING PROCESS
8.4.1 KEY BUYING CRITERIA
8.5 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.6 UNMET NEEDS FROM VARIOUS END USERS
8.6.1 UNMET NEEDS
8.6.2 END USER EXPECTATIONS
8.7 MARKET PROFITABILITY
9 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING
9.1 INTRODUCTION
9.2 SOFTWARE
9.2.1 ENTIRE SUPPLY CHAIN SUITES
9.2.1.1 Need for end-to-end visibility and real-time insights drives market growth
9.2.2 SUPPLY CHAIN PLANNING SOFTWARE
9.2.2.1 Need for effective and efficient supply chain planning to fuel market growth
9.2.3 SUPPLIER RELATIONSHIP MANAGEMENT (SRM)
9.2.3.1 Benefit of enhanced supplier collaboration to drive segment growth
9.2.4 SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT
9.2.4.1 Need for effective supply chain business network to drive growth of segment
9.2.5 SUPPLY CHAIN COST-TO-SERVE ANALYSIS
9.2.5.1 Pressing need to cut costs and improve operational efficiency to drive growth
9.2.6 SUPPLY CHAIN ANALYTICS SOFTWARE
9.2.6.1 Advancement of artificial intelligence in data analytics to drive market growth
9.2.7 SUPPLY CHAIN VISIBILITY SOFTWARE
9.2.7.1 Need for greater visibility and maintenance across supply chain to drive market growth
9.3 HARDWARE
9.3.1 BARCODES & BARCODE SCANNERS
9.3.1.1 Need for better tracking and traceability of medical devices to drive market growth
9.3.2 SYSTEMS
9.3.2.1 Advantages of smart cabinets in effective inventory management to drive segment growth
9.3.3 RFID TAGS & READERS
9.3.3.1 Crucial role of RFIDs in asset tracking, and inventory management to drive market growth
9.3.4 OTHER HARDWARE COMPONENTS
9.4 SERVICES
9.4.1 MANAGED SERVICES
9.4.1.1 Ability to focus on core business activities to drive demand for managed services
9.4.2 PROFESSIONAL SERVICES
9.4.2.1 Benefits of running supply chains with expert advice to drive demand for professional services
10 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION
10.1 INTRODUCTION
10.2 PURCHASING MANAGEMENT
10.2.1 SUPPLY MANAGEMENT
10.2.2 PROCUREMENT
10.2.3 CAPITAL PURCHASING
10.2.4 STRATEGIC SOURCING
10.2.5 TRANSPORTATION MANAGEMENT
10.3 INVENTORY MANAGEMENT
10.3.1 ORDER MANAGEMENT
10.3.2 WAREHOUSE MANAGEMENT
10.3.3 CONSIGNMENT MANAGEMENT
10.3.4 IMPLANT MANAGEMENT
10.3.5 TISSUE MANAGEMENT
11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY
11.2.1 DRIVING GROWTH IN HEALTHCARE THROUGH ADVANCED SUPPLY CHAIN SOLUTIONS FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
11.2.2 SMALL MOLECULES
11.2.2.1 Driving growth through optimized supply chain solutions for small molecule drugs
11.2.3 VACCINES
11.2.3.1 Driving growth in healthcare through advanced solutions for vaccine distribution and innovation
11.2.4 MONOCLONAL ANTIBODIES, BIOSIMILARS & MRNA
11.2.4.1 Revolutionizing healthcare with advanced biotech therapies and evolving supply chain demands
11.2.5 CELL AND GENE THERAPY (CGT)
11.2.5.1 Driving innovation in cell and gene therapy through strategic supply chain solutions
11.2.6 OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
11.3 MEDICAL DEVICES & EQUIPMENT
11.3.1 TRANSFORMING HEALTHCARE WITH ADVANCED MANAGEMENT OF MEDICAL DEVICES AND EQUIPMENT
11.3.2 SURGICAL INSTRUMENTS
11.3.2.1 Advancing surgical care through enhanced management of surgical instruments and logistics
11.3.3 DIAGNOSTICS & THERAPEUTICS EQUIPMENT
11.3.3.1 Revolutionizing patient care through advancements in diagnostics and therapeutics equipment
11.3.4 MONITORING DEVICES
11.3.4.1 Driving growth in healthcare through advanced monitoring devices and remote patient monitoring solutions
11.3.5 IMPLANTS & PROSTHETICS
11.3.5.1 Enhancing patient care through advanced monitoring devices and real-time health data management
11.3.6 OTHER MEDICAL DEVICES & EQUIPMENT
11.4 OTHERS
12 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL
12.1 INTRODUCTION
12.2 ON-PREMISE MODEL
12.3 CLOUD-BASED MODEL
13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER
13.1 INTRODUCTION
13.2 MANUFACTURERS
13.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.2.1.1 Complex regulatory requirements to drive growth of segment
13.2.2 MEDICAL & SURGICAL DEVICE MANUFACTURERS
13.2.2.1 Growing demand for medical devices and greater emphasis on supply chain resilience
13.3 DISTRIBUTORS
13.3.1 PRIMARY PHARMACEUTICAL DISTRIBUTORS
13.3.1.1 Expanding distribution infrastructure to improve pharmaceutical supply reliability
13.3.2 WHOLESALERS
13.3.2.1 Critical importance of wholesalers in bridging gap between manufacturers and end users to drive segment
13.3.3 GROUP PURCHASING ORGANIZATIONS (GPOS)
13.3.3.1 Role in optimizing supply chains by simplifying procurement processes to boost market growth
13.4 HEALTHCARE PROVIDERS
13.4.1 HOSPITALS & CLINICS
13.4.1.1 Need for efficient inventory management in hospitals to drive market growth
13.4.2 PHARMACIES
13.4.2.1 Ability to curb challenges faced by pharmacies in supply chain management to drive growth
13.4.3 AMBULATORY SURGICAL CENTERS
13.4.3.1 Effective inventory management to avoid overstocking or shortages to fuel the market expansion
13.4.4 OTHER HEALTHCARE PROVIDERS
14 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
14.2.2 US
14.2.2.1 Growing collaborations among market players to drive market
14.2.3 CANADA
14.2.3.1 increasing adoption of digital technologies to promote growth
14.3 EUROPE
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
14.3.2 GERMANY
14.3.2.1 Booming medical device market to propel market
14.3.3 UK
14.3.3.1 Key initiatives by NHS to drive market growth
14.3.4 FRANCE
14.3.4.1 Evolving digital health landscape to augment growth
14.3.5 SPAIN
14.3.5.1 Rise in chronic diseases to encourage growth
14.3.6 ITALY
14.3.6.1 Increasing initiatives in pharmaceutical and healthcare sectors to aid growth
14.3.7 NORDIC COUNTRIES
14.3.7.1 Increasing investments and expansion initiatives by prominent companies to accelerate growth
14.3.8 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
14.4.2 JAPAN
14.4.2.1 Dominant aging population to accelerate growth
14.4.3 CHINA
14.4.3.1 Government Policies, and Technological Advancements Propel Growth in Healthcare Supply Chain
14.4.4 INDIA
14.4.4.1 Increasing healthcare access to spur growth
14.4.5 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
14.5.2 BRAZIL
14.5.2.1 Regulatory demands to strengthen healthcare supply chain to drive growth
14.5.3 MEXICO
14.5.3.1 Growing foreign investment to boost market
14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
14.6.2 GCC COUNTRIES
14.6.2.1 Rising healthcare investments to facilitate growth
14.6.3 REST OF MIDDLE EAST & AFRICA
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGY/RIGHT TO WIN
15.3 REVENUE ANALYSIS, 2021–2025
15.4 MARKET SHARE ANALYSIS, 2025
15.5 BRAND/PRODUCT COMPARISON
15.6 COMPANY VALUATION & FINANCIAL METRICS
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.7.1 STARS
15.7.2 EMERGING LEADERS
15.7.3 PERVASIVE PLAYERS
15.7.4 PARTICIPANTS
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.7.5.1 Company footprint
15.7.5.2 Region footprint
15.7.5.3 Offering footprint
15.7.5.4 Function footprint
15.7.5.5 End user footprint
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.8.1 PROGRESSIVE COMPANIES
15.8.2 RESPONSIVE COMPANIES
15.8.3 DYNAMIC COMPANIES
15.8.4 STARTING BLOCKS
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
15.9.3 OTHER DEVELOPMENTS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 SAP SE
16.1.1.1 Business overview
16.1.1.2 Products/Services/Solutions offered
16.1.1.3 Recent developments
16.1.1.3.1 Product launches & upgrades
16.1.1.3.2 Deals
16.1.1.3.3 Expansions
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 ORACLE
16.1.2.1 Business overview
16.1.2.2 Products/Services/Solutions offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches & upgrades
16.1.2.3.2 Deals
16.1.2.3.3 Expansions
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 IBM
16.1.3.1 Business overview
16.1.3.2 Products/Services/Solutions offered
16.1.3.3 Recent developments
16.1.3.3.1 Product Launches & Upgrades
16.1.3.3.2 Deals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 CARDINAL HEALTH
16.1.4.1 Business overview
16.1.4.2 Products/Services/Solutions offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches & upgrades
16.1.4.3.2 Deals
16.1.4.3.3 Expansions
16.1.4.4 MnM view
16.1.4.4.1 Right to win
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 INFOR
16.1.5.1 Business overview
16.1.5.2 Products/Services/Solutions offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches & upgrades
16.1.5.3.2 Deals
16.1.5.4 MnM view
16.1.5.4.1 Right to win
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses & competitive threats
16.1.6 MANHATTAN ASSOCIATES
16.1.6.1 Business overview
16.1.6.2 Products/Services/Solutions offered
16.1.6.3 Recent developments
16.1.6.3.1 Product launches & upgrades
16.1.6.3.2 Deals
16.1.7 TECSYS
16.1.7.1 Business overview
16.1.7.2 Products/Services/Solutions offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches & upgrades
16.1.7.3.2 Deals
16.1.8 MCKESSON
16.1.8.1 Business overview
16.1.8.2 Products/Services/Solutions offered
16.1.8.3 Recent developments
16.1.8.3.1 Product launches & upgrades
16.1.8.3.2 Deals
16.1.9 MEDLINE
16.1.9.1 Business overview
16.1.9.2 Products/Services/Solutions offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches & upgrades
16.1.9.3.2 Deals
16.1.10 GLOBAL HEALTHCARE EXCHANGE, LLC
16.1.10.1 Business overview
16.1.10.2 Products/Services/Solutions offered
16.1.10.3 Recent developments
16.1.10.3.1 Product launches & upgrades
16.1.10.3.2 Deals
16.1.10.3.3 Expansions
16.1.11 EPICOR SOFTWARE CORPORATION
16.1.11.1 Business overview
16.1.11.2 Products/Services/Solutions offered
16.1.11.3 Recent developments
16.1.11.3.1 Product launches & upgrades
16.1.11.3.2 Deals
16.1.12 CORCENTRIC, INC.
16.1.12.1 Business overview
16.1.12.2 Products/Services/Solutions offered
16.1.12.3 Recent developments
16.1.12.3.1 Product launches & upgrades
16.1.12.3.2 Deals
16.1.13 COUPA
16.1.13.1 Business overview
16.1.13.2 Products/Services/Solutions offered
16.1.13.3 Recent developments
16.1.13.3.1 Product launches & upgrades
16.1.13.3.2 Deals
16.1.13.3.3 Expansions
16.1.14 BLUE YONDER GROUP, INC.
16.1.14.1 Business overview
16.1.14.2 Products/Services/Solutions offered
16.1.14.3 Recent developments
16.1.14.3.1 Product Launches & Upgrades
16.1.14.3.2 Deals
16.1.15 LOGITAG SYSTEMS
16.1.15.1 Business overview
16.1.15.2 Products/Services/Solutions offered
16.1.16 WORKDAY, INC.
16.1.16.1 Business overview
16.1.16.2 Products/Services/Solutions offered
16.1.16.3 Recent developments
16.1.16.3.1 Product launches & upgrades
16.1.16.3.2 Deals
16.1.17 ARVATO SYSTEMS
16.1.17.1 Business overview
16.1.17.2 Products/Services/Solutions offered
16.1.17.3 Recent developments
16.1.17.3.1 Product launches & upgrades
16.1.17.3.2 Deals
16.1.18 CENCORA, INC.
16.1.18.1 Business overview
16.1.18.2 Products/Services/Solutions offered
16.1.18.3 Recent developments
16.1.18.3.1 Product launches & upgrades
16.1.18.3.2 Deals
16.1.18.3.3 Expansions
16.1.19 GEP
16.1.19.1 Business overview
16.1.19.2 Products/Services/Solutions offered
16.1.19.3 Recent developments
16.1.19.3.1 Product launches & upgrades
16.1.19.3.2 Deals
16.1.20 VIZIENT, INC.
16.1.20.1 Business overview
16.1.20.2 Products/Services/Solutions offered
16.1.20.3 Recent developments
16.1.20.3.1 Product launches & upgrades
16.1.20.3.2 Deals
16.2 OTHER PLAYERS
16.2.1 JUMP TECHNOLOGIES, INC.
16.2.2 MEDICAL TRACKING SOLUTIONS, INC.
16.2.3 PROMEDEO
16.2.4 PROCUREMENT PARTNERS
16.2.5 INBEAM TECHNOLOGIES
17 RESEARCH METHODOLOGY
17.1 RESEARCH APPROACH
17.1.1 SECONDARY RESEARCH
17.1.1.1 Key data from secondary sources
17.1.2 PRIMARY RESEARCH
17.1.2.1 Key data from primary sources
17.1.2.2 Insights from primary experts
17.2 RESEARCH METHODOLOGY
17.3 MARKET SIZE ESTIMATION
17.4 MARKET BREAKDOWN DATA TRIANGULATION
17.5 MARKET SHARE ESTIMATION
17.6 STUDY ASSUMPTIONS
17.7 LIMITATIONS
17.7.1 SCOPE-RELATED LIMITATIONS
17.7.2 METHODOLOGY-RELATED LIMITATIONS
17.8 RISK ASSESSMENT
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW
3.2 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING AND COUNTRY
3.3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing pressure on healthcare providers to improve operational efficiency and profitability
4.2.1.2 Rising demand for healthcare services due to population growth and aging demographics
4.2.1.3 Focus on reducing supply chain costs
4.2.1.4 Demand for transparency and traceability
4.2.1.5 Availability of funding, investments, and partnerships
4.2.1.6 Large-scale drug counterfeiting in pharmaceutical industry
4.2.2 RESTRAINTS
4.2.2.1 High implementation costs for advanced technologies
4.2.2.2 Data security and privacy concerns
4.2.2.3 Supply chain disruptions due to global events or geopolitical tensions
4.2.3 OPPORTUNITIES
4.2.3.1 Increasing use of AI-powered solutions
4.2.3.2 Expansion into emerging markets with growing healthcare demands
4.2.3.3 Enhanced focus on sustainability and eco-friendly practices in healthcare logistics
4.2.4 CHALLENGES
4.2.4.1 Complex and varying regulatory requirements across regions
4.2.4.2 Shortage of skilled professionals to manage sophisticated systems
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER'S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 THREAT OF NEW ENTRANTS
5.1.5 BARGAINING POWER OF SUPPLIERS
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & PRODUCT DEVELOPMENT
5.3.2 TECHNOLOGY INFRASTRUCTURE
5.3.3 PLATFORM DEVELOPMENT
5.3.4 DISTRIBUTION
5.3.5 MARKETING & SALES
5.3.6 POST-SALES SERVICES
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE PRICE OF HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY OFFERING (2025)
5.5.2 INDICATIVE PRICE FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY REGION (2025)
5.6 KEY CONFERENCES & EVENTS, 2026–2027
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 CASE STUDY ANALYSIS
5.10 IMPACT OF US TARIFF OVERVIEW
5.10.1 INTRODUCTION
5.10.2 KEY TARIFF RATES
5.10.3 PRICE IMPACT ANALYSIS
5.10.4 IMPACT ON COUNTRY/REGION
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia Pacific
5.10.5 IMPACT ON END USERS
5.10.5.1 Manufacturers
5.10.5.2 Distributors
5.10.5.3 Healthcare providers
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 BLOCKCHAIN
6.1.2 ARTIFICIAL INTELLIGENCE & MACHINE LEARNING
6.1.3 CLOUD COMPUTING
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 DATA ANALYTICS
6.2.2 INTERNET OF THINGS
6.3 ADJACENT TECHNOLOGIES
6.3.1 AR/VR
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
6.5.1 PATENT PUBLICATION TRENDS
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 AI-ASSISTED PROCUREMENT AND PREDICTIVE INVENTORY MANAGEMENT
6.6.2 REAL-TIME SUPPLY CHAIN VISIBILITY AND INTELLIGENT AUTOMATION
6.6.3 PREDICTIVE SUPPLY CHAIN RISK MANAGEMENT AND RESILIENCE
6.7 IMPACT OF AI/GEN AI IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
6.7.1 KEY USE CASES
6.7.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
6.7.2.1 Case Study 1: Enhancing supply chain with AI Solutions at NHS Blood and Transplant
6.7.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
6.7.3.1 Case Study 2: Leveraging AI for Proactive Infection Prevention in Hospital
6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEM
6.7.4.1 Healthcare IT ecosystem
6.7.4.2 Supply chain management market
6.7.4.3 Cloud ERP market
6.7.5 USERS READINESS AND IMPACT ASSESSMENT
6.7.5.1 User readiness
6.7.5.1.1 User A: Manufacturers
6.7.5.1.2 User B: Distributors
6.7.5.1.3 User C: Providers
6.7.5.2 Impact assessment
6.7.5.2.1 User A: Manufacturers
6.7.5.2.1.1 Implementation
6.7.5.2.1.2 Impact
6.7.5.2.2 User B: Distributors
6.7.5.2.2.1 Implementation
6.7.5.2.2.2 Impact
6.7.5.2.3 User C: Providers
6.7.5.2.3.1 Implementation
6.7.5.2.3.2 Impact
7 REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Middle East & Africa
7.1.2.5 Latin America
7.1.3 INDUSTRY STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.4 KEY STAKEHOLDERS IN BUYING PROCESS
8.4.1 KEY BUYING CRITERIA
8.5 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.6 UNMET NEEDS FROM VARIOUS END USERS
8.6.1 UNMET NEEDS
8.6.2 END USER EXPECTATIONS
8.7 MARKET PROFITABILITY
9 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING
9.1 INTRODUCTION
9.2 SOFTWARE
9.2.1 ENTIRE SUPPLY CHAIN SUITES
9.2.1.1 Need for end-to-end visibility and real-time insights drives market growth
9.2.2 SUPPLY CHAIN PLANNING SOFTWARE
9.2.2.1 Need for effective and efficient supply chain planning to fuel market growth
9.2.3 SUPPLIER RELATIONSHIP MANAGEMENT (SRM)
9.2.3.1 Benefit of enhanced supplier collaboration to drive segment growth
9.2.4 SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT
9.2.4.1 Need for effective supply chain business network to drive growth of segment
9.2.5 SUPPLY CHAIN COST-TO-SERVE ANALYSIS
9.2.5.1 Pressing need to cut costs and improve operational efficiency to drive growth
9.2.6 SUPPLY CHAIN ANALYTICS SOFTWARE
9.2.6.1 Advancement of artificial intelligence in data analytics to drive market growth
9.2.7 SUPPLY CHAIN VISIBILITY SOFTWARE
9.2.7.1 Need for greater visibility and maintenance across supply chain to drive market growth
9.3 HARDWARE
9.3.1 BARCODES & BARCODE SCANNERS
9.3.1.1 Need for better tracking and traceability of medical devices to drive market growth
9.3.2 SYSTEMS
9.3.2.1 Advantages of smart cabinets in effective inventory management to drive segment growth
9.3.3 RFID TAGS & READERS
9.3.3.1 Crucial role of RFIDs in asset tracking, and inventory management to drive market growth
9.3.4 OTHER HARDWARE COMPONENTS
9.4 SERVICES
9.4.1 MANAGED SERVICES
9.4.1.1 Ability to focus on core business activities to drive demand for managed services
9.4.2 PROFESSIONAL SERVICES
9.4.2.1 Benefits of running supply chains with expert advice to drive demand for professional services
10 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION
10.1 INTRODUCTION
10.2 PURCHASING MANAGEMENT
10.2.1 SUPPLY MANAGEMENT
10.2.2 PROCUREMENT
10.2.3 CAPITAL PURCHASING
10.2.4 STRATEGIC SOURCING
10.2.5 TRANSPORTATION MANAGEMENT
10.3 INVENTORY MANAGEMENT
10.3.1 ORDER MANAGEMENT
10.3.2 WAREHOUSE MANAGEMENT
10.3.3 CONSIGNMENT MANAGEMENT
10.3.4 IMPLANT MANAGEMENT
10.3.5 TISSUE MANAGEMENT
11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED
11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY
11.2.1 DRIVING GROWTH IN HEALTHCARE THROUGH ADVANCED SUPPLY CHAIN SOLUTIONS FOR PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
11.2.2 SMALL MOLECULES
11.2.2.1 Driving growth through optimized supply chain solutions for small molecule drugs
11.2.3 VACCINES
11.2.3.1 Driving growth in healthcare through advanced solutions for vaccine distribution and innovation
11.2.4 MONOCLONAL ANTIBODIES, BIOSIMILARS & MRNA
11.2.4.1 Revolutionizing healthcare with advanced biotech therapies and evolving supply chain demands
11.2.5 CELL AND GENE THERAPY (CGT)
11.2.5.1 Driving innovation in cell and gene therapy through strategic supply chain solutions
11.2.6 OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
11.3 MEDICAL DEVICES & EQUIPMENT
11.3.1 TRANSFORMING HEALTHCARE WITH ADVANCED MANAGEMENT OF MEDICAL DEVICES AND EQUIPMENT
11.3.2 SURGICAL INSTRUMENTS
11.3.2.1 Advancing surgical care through enhanced management of surgical instruments and logistics
11.3.3 DIAGNOSTICS & THERAPEUTICS EQUIPMENT
11.3.3.1 Revolutionizing patient care through advancements in diagnostics and therapeutics equipment
11.3.4 MONITORING DEVICES
11.3.4.1 Driving growth in healthcare through advanced monitoring devices and remote patient monitoring solutions
11.3.5 IMPLANTS & PROSTHETICS
11.3.5.1 Enhancing patient care through advanced monitoring devices and real-time health data management
11.3.6 OTHER MEDICAL DEVICES & EQUIPMENT
11.4 OTHERS
12 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL
12.1 INTRODUCTION
12.2 ON-PREMISE MODEL
12.3 CLOUD-BASED MODEL
13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER
13.1 INTRODUCTION
13.2 MANUFACTURERS
13.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
13.2.1.1 Complex regulatory requirements to drive growth of segment
13.2.2 MEDICAL & SURGICAL DEVICE MANUFACTURERS
13.2.2.1 Growing demand for medical devices and greater emphasis on supply chain resilience
13.3 DISTRIBUTORS
13.3.1 PRIMARY PHARMACEUTICAL DISTRIBUTORS
13.3.1.1 Expanding distribution infrastructure to improve pharmaceutical supply reliability
13.3.2 WHOLESALERS
13.3.2.1 Critical importance of wholesalers in bridging gap between manufacturers and end users to drive segment
13.3.3 GROUP PURCHASING ORGANIZATIONS (GPOS)
13.3.3.1 Role in optimizing supply chains by simplifying procurement processes to boost market growth
13.4 HEALTHCARE PROVIDERS
13.4.1 HOSPITALS & CLINICS
13.4.1.1 Need for efficient inventory management in hospitals to drive market growth
13.4.2 PHARMACIES
13.4.2.1 Ability to curb challenges faced by pharmacies in supply chain management to drive growth
13.4.3 AMBULATORY SURGICAL CENTERS
13.4.3.1 Effective inventory management to avoid overstocking or shortages to fuel the market expansion
13.4.4 OTHER HEALTHCARE PROVIDERS
14 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
14.2.2 US
14.2.2.1 Growing collaborations among market players to drive market
14.2.3 CANADA
14.2.3.1 increasing adoption of digital technologies to promote growth
14.3 EUROPE
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
14.3.2 GERMANY
14.3.2.1 Booming medical device market to propel market
14.3.3 UK
14.3.3.1 Key initiatives by NHS to drive market growth
14.3.4 FRANCE
14.3.4.1 Evolving digital health landscape to augment growth
14.3.5 SPAIN
14.3.5.1 Rise in chronic diseases to encourage growth
14.3.6 ITALY
14.3.6.1 Increasing initiatives in pharmaceutical and healthcare sectors to aid growth
14.3.7 NORDIC COUNTRIES
14.3.7.1 Increasing investments and expansion initiatives by prominent companies to accelerate growth
14.3.8 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
14.4.2 JAPAN
14.4.2.1 Dominant aging population to accelerate growth
14.4.3 CHINA
14.4.3.1 Government Policies, and Technological Advancements Propel Growth in Healthcare Supply Chain
14.4.4 INDIA
14.4.4.1 Increasing healthcare access to spur growth
14.4.5 REST OF ASIA PACIFIC
14.5 LATIN AMERICA
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
14.5.2 BRAZIL
14.5.2.1 Regulatory demands to strengthen healthcare supply chain to drive growth
14.5.3 MEXICO
14.5.3.1 Growing foreign investment to boost market
14.5.4 REST OF LATIN AMERICA
14.6 MIDDLE EAST & AFRICA
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
14.6.2 GCC COUNTRIES
14.6.2.1 Rising healthcare investments to facilitate growth
14.6.3 REST OF MIDDLE EAST & AFRICA
15 COMPETITIVE LANDSCAPE
15.1 INTRODUCTION
15.2 KEY PLAYER STRATEGY/RIGHT TO WIN
15.3 REVENUE ANALYSIS, 2021–2025
15.4 MARKET SHARE ANALYSIS, 2025
15.5 BRAND/PRODUCT COMPARISON
15.6 COMPANY VALUATION & FINANCIAL METRICS
15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
15.7.1 STARS
15.7.2 EMERGING LEADERS
15.7.3 PERVASIVE PLAYERS
15.7.4 PARTICIPANTS
15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
15.7.5.1 Company footprint
15.7.5.2 Region footprint
15.7.5.3 Offering footprint
15.7.5.4 Function footprint
15.7.5.5 End user footprint
15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
15.8.1 PROGRESSIVE COMPANIES
15.8.2 RESPONSIVE COMPANIES
15.8.3 DYNAMIC COMPANIES
15.8.4 STARTING BLOCKS
15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
15.9 COMPETITIVE SCENARIO
15.9.1 PRODUCT LAUNCHES & APPROVALS
15.9.2 DEALS
15.9.3 OTHER DEVELOPMENTS
16 COMPANY PROFILES
16.1 KEY PLAYERS
16.1.1 SAP SE
16.1.1.1 Business overview
16.1.1.2 Products/Services/Solutions offered
16.1.1.3 Recent developments
16.1.1.3.1 Product launches & upgrades
16.1.1.3.2 Deals
16.1.1.3.3 Expansions
16.1.1.4 MnM view
16.1.1.4.1 Right to win
16.1.1.4.2 Strategic choices
16.1.1.4.3 Weaknesses & competitive threats
16.1.2 ORACLE
16.1.2.1 Business overview
16.1.2.2 Products/Services/Solutions offered
16.1.2.3 Recent developments
16.1.2.3.1 Product launches & upgrades
16.1.2.3.2 Deals
16.1.2.3.3 Expansions
16.1.2.4 MnM view
16.1.2.4.1 Right to win
16.1.2.4.2 Strategic choices
16.1.2.4.3 Weaknesses & competitive threats
16.1.3 IBM
16.1.3.1 Business overview
16.1.3.2 Products/Services/Solutions offered
16.1.3.3 Recent developments
16.1.3.3.1 Product Launches & Upgrades
16.1.3.3.2 Deals
16.1.3.4 MnM view
16.1.3.4.1 Right to win
16.1.3.4.2 Strategic choices
16.1.3.4.3 Weaknesses & competitive threats
16.1.4 CARDINAL HEALTH
16.1.4.1 Business overview
16.1.4.2 Products/Services/Solutions offered
16.1.4.3 Recent developments
16.1.4.3.1 Product launches & upgrades
16.1.4.3.2 Deals
16.1.4.3.3 Expansions
16.1.4.4 MnM view
16.1.4.4.1 Right to win
16.1.4.4.2 Strategic choices
16.1.4.4.3 Weaknesses & competitive threats
16.1.5 INFOR
16.1.5.1 Business overview
16.1.5.2 Products/Services/Solutions offered
16.1.5.3 Recent developments
16.1.5.3.1 Product launches & upgrades
16.1.5.3.2 Deals
16.1.5.4 MnM view
16.1.5.4.1 Right to win
16.1.5.4.2 Strategic choices
16.1.5.4.3 Weaknesses & competitive threats
16.1.6 MANHATTAN ASSOCIATES
16.1.6.1 Business overview
16.1.6.2 Products/Services/Solutions offered
16.1.6.3 Recent developments
16.1.6.3.1 Product launches & upgrades
16.1.6.3.2 Deals
16.1.7 TECSYS
16.1.7.1 Business overview
16.1.7.2 Products/Services/Solutions offered
16.1.7.3 Recent developments
16.1.7.3.1 Product launches & upgrades
16.1.7.3.2 Deals
16.1.8 MCKESSON
16.1.8.1 Business overview
16.1.8.2 Products/Services/Solutions offered
16.1.8.3 Recent developments
16.1.8.3.1 Product launches & upgrades
16.1.8.3.2 Deals
16.1.9 MEDLINE
16.1.9.1 Business overview
16.1.9.2 Products/Services/Solutions offered
16.1.9.3 Recent developments
16.1.9.3.1 Product launches & upgrades
16.1.9.3.2 Deals
16.1.10 GLOBAL HEALTHCARE EXCHANGE, LLC
16.1.10.1 Business overview
16.1.10.2 Products/Services/Solutions offered
16.1.10.3 Recent developments
16.1.10.3.1 Product launches & upgrades
16.1.10.3.2 Deals
16.1.10.3.3 Expansions
16.1.11 EPICOR SOFTWARE CORPORATION
16.1.11.1 Business overview
16.1.11.2 Products/Services/Solutions offered
16.1.11.3 Recent developments
16.1.11.3.1 Product launches & upgrades
16.1.11.3.2 Deals
16.1.12 CORCENTRIC, INC.
16.1.12.1 Business overview
16.1.12.2 Products/Services/Solutions offered
16.1.12.3 Recent developments
16.1.12.3.1 Product launches & upgrades
16.1.12.3.2 Deals
16.1.13 COUPA
16.1.13.1 Business overview
16.1.13.2 Products/Services/Solutions offered
16.1.13.3 Recent developments
16.1.13.3.1 Product launches & upgrades
16.1.13.3.2 Deals
16.1.13.3.3 Expansions
16.1.14 BLUE YONDER GROUP, INC.
16.1.14.1 Business overview
16.1.14.2 Products/Services/Solutions offered
16.1.14.3 Recent developments
16.1.14.3.1 Product Launches & Upgrades
16.1.14.3.2 Deals
16.1.15 LOGITAG SYSTEMS
16.1.15.1 Business overview
16.1.15.2 Products/Services/Solutions offered
16.1.16 WORKDAY, INC.
16.1.16.1 Business overview
16.1.16.2 Products/Services/Solutions offered
16.1.16.3 Recent developments
16.1.16.3.1 Product launches & upgrades
16.1.16.3.2 Deals
16.1.17 ARVATO SYSTEMS
16.1.17.1 Business overview
16.1.17.2 Products/Services/Solutions offered
16.1.17.3 Recent developments
16.1.17.3.1 Product launches & upgrades
16.1.17.3.2 Deals
16.1.18 CENCORA, INC.
16.1.18.1 Business overview
16.1.18.2 Products/Services/Solutions offered
16.1.18.3 Recent developments
16.1.18.3.1 Product launches & upgrades
16.1.18.3.2 Deals
16.1.18.3.3 Expansions
16.1.19 GEP
16.1.19.1 Business overview
16.1.19.2 Products/Services/Solutions offered
16.1.19.3 Recent developments
16.1.19.3.1 Product launches & upgrades
16.1.19.3.2 Deals
16.1.20 VIZIENT, INC.
16.1.20.1 Business overview
16.1.20.2 Products/Services/Solutions offered
16.1.20.3 Recent developments
16.1.20.3.1 Product launches & upgrades
16.1.20.3.2 Deals
16.2 OTHER PLAYERS
16.2.1 JUMP TECHNOLOGIES, INC.
16.2.2 MEDICAL TRACKING SOLUTIONS, INC.
16.2.3 PROMEDEO
16.2.4 PROCUREMENT PARTNERS
16.2.5 INBEAM TECHNOLOGIES
17 RESEARCH METHODOLOGY
17.1 RESEARCH APPROACH
17.1.1 SECONDARY RESEARCH
17.1.1.1 Key data from secondary sources
17.1.2 PRIMARY RESEARCH
17.1.2.1 Key data from primary sources
17.1.2.2 Insights from primary experts
17.2 RESEARCH METHODOLOGY
17.3 MARKET SIZE ESTIMATION
17.4 MARKET BREAKDOWN DATA TRIANGULATION
17.5 MARKET SHARE ESTIMATION
17.6 STUDY ASSUMPTIONS
17.7 LIMITATIONS
17.7.1 SCOPE-RELATED LIMITATIONS
17.7.2 METHODOLOGY-RELATED LIMITATIONS
17.8 RISK ASSESSMENT
18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
TABLE 2 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ROLE IN ECOSYSTEM
TABLE 4 INDICATIVE PRICE OF HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY OFFERING (2025)
TABLE 5 INDICATIVE PRICE FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY REGION (2025)
TABLE 6 HEALTHCARE SUPPLY CHAIN MANAGEMENT: KEY CONFERENCES AND EVENTS (2026–2027)
TABLE 7 CASE STUDY 1: IMPROVING SUPPLY CHAIN VISIBILITY ACROSS 70 HOSPITALS AT COMMUNITY HEALTH SYSTEMS
TABLE 8 CASE STUDY: TRANSFORMING SUPPLY CHAIN AT DAYTON CHILDREN’S HOSPITAL
TABLE 9 CASE STUDY 3: OLYMPUS CORPORATION PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT
TABLE 10 CASE STUDY 4: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12 TOP APPLICANTS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT
TABLE 13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: KEY PATENTS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA
TABLE 20 REGULATORY SCENARIO OF EUROPE
TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 22 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 23 REGULATORY SCENARIO OF LATIN AMERICA
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 26 UNMET NEEDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
TABLE 27 END USER EXPECTATIONS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
TABLE 28 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 29 HEALTHCARE SUPPLY CHAIN MANAGEMENT SOFTWARE AND THEIR OFFERINGS
TABLE 30 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 31 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ENTIRE SUPPLY CHAIN SUITES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN PLANNING SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLIER RELATIONSHIP MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN COST-TO-SERVE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN ANALYTICS SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN VISIBILITY SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR BARCODES & BARCODE SCANNERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR RFID TAGS & READERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HARDWARE COMPONENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 46 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANAGED SERVICES, BY COUNTRY 2024–2031 (USD MILLION)
TABLE 48 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 50 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 51 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROCUREMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CAPITAL PURCHASING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR STRATEGIC SOURCING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TRANSPORTATION MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 58 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ORDER MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WAREHOUSE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CONSIGNMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TISSUE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 65 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SMALL MOLECULES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONOCLONAL ANTIBODIES, BIOSIMILARS & MRNA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CELL & GENE THERAPY (CGT), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 73 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE FOR MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SURGICAL INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DIAGNOSTICS & THERAPEUTIC EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONITORING DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANTS & PROSTHETICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 81 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ON-PREMISE MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 84 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL & SURGICAL DEVICE MANUFACTURERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PRIMARY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WHOLESALERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY 2024–2031 (USD MILLION)
TABLE 96 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 100 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 102 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 106 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 109 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 112 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION)
TABLE 115 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 117 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 119 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 121 US : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 124 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 127 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 129 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION)
TABLE 130 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 132 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 136 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 139 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 142 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 143 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION)
TABLE 145 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 148 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 152 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 155 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 158 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 162 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 163 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 167 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 170 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 173 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 174 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 178 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 182 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 185 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 188 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 189 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 193 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 197 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 200 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 203 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 204 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 208 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 212 SPAIN : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 215 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 218 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 219 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 223 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 224 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 227 ITALY : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 230 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 233 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 234 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 235 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 238 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 242 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 245 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 248 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 249 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 253 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 254 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 257 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 260 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 261 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 263 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 264 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 268 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 269 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 273 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 275 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 276 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 279 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 280 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 284 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 288 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 291 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 294 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 295 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298 CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 299 CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD
TABLE 2 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ROLE IN ECOSYSTEM
TABLE 4 INDICATIVE PRICE OF HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY OFFERING (2025)
TABLE 5 INDICATIVE PRICE FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT, BY REGION (2025)
TABLE 6 HEALTHCARE SUPPLY CHAIN MANAGEMENT: KEY CONFERENCES AND EVENTS (2026–2027)
TABLE 7 CASE STUDY 1: IMPROVING SUPPLY CHAIN VISIBILITY ACROSS 70 HOSPITALS AT COMMUNITY HEALTH SYSTEMS
TABLE 8 CASE STUDY: TRANSFORMING SUPPLY CHAIN AT DAYTON CHILDREN’S HOSPITAL
TABLE 9 CASE STUDY 3: OLYMPUS CORPORATION PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT
TABLE 10 CASE STUDY 4: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS
TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 12 TOP APPLICANTS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT
TABLE 13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: KEY PATENTS
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA
TABLE 20 REGULATORY SCENARIO OF EUROPE
TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 22 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 23 REGULATORY SCENARIO OF LATIN AMERICA
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 26 UNMET NEEDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
TABLE 27 END USER EXPECTATIONS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
TABLE 28 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 29 HEALTHCARE SUPPLY CHAIN MANAGEMENT SOFTWARE AND THEIR OFFERINGS
TABLE 30 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 31 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 32 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ENTIRE SUPPLY CHAIN SUITES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN PLANNING SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 34 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLIER RELATIONSHIP MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 35 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN COST-TO-SERVE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN ANALYTICS SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY CHAIN VISIBILITY SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR BARCODES & BARCODE SCANNERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR RFID TAGS & READERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HARDWARE COMPONENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 46 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 47 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANAGED SERVICES, BY COUNTRY 2024–2031 (USD MILLION)
TABLE 48 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROFESSIONAL SERVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 50 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 51 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SUPPLY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PROCUREMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CAPITAL PURCHASING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR STRATEGIC SOURCING, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TRANSPORTATION MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 58 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ORDER MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WAREHOUSE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CONSIGNMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR TISSUE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 65 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 66 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SMALL MOLECULES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR VACCINES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONOCLONAL ANTIBODIES, BIOSIMILARS & MRNA, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CELL & GENE THERAPY (CGT), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 71 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 73 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE FOR MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 74 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SURGICAL INSTRUMENTS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DIAGNOSTICS & THERAPEUTIC EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MONITORING DEVICES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR IMPLANTS & PROSTHETICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER MEDICAL DEVICES & EQUIPMENT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 81 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR ON-PREMISE MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR CLOUD-BASED MODELS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 84 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 85 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL & SURGICAL DEVICE MANUFACTURERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 89 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PRIMARY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 91 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR WHOLESALERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 92 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 95 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY 2024–2031 (USD MILLION)
TABLE 96 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 100 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 102 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 106 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 107 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 108 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 109 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 110 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 111 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 112 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 113 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION)
TABLE 115 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 117 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 119 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 121 US : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 123 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 124 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 127 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 128 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 129 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION)
TABLE 130 US: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 131 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 132 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 136 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 139 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 141 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 142 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 143 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE 2024–2031 (USD MILLION)
TABLE 145 CANADA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 147 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 148 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 150 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 152 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 155 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 158 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 159 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 160 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 162 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 163 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 167 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 170 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 172 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 173 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 174 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176 GERMANY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 178 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 180 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 182 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 183 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 185 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 188 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 189 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 190 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 UK: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 192 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 193 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 197 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 200 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 202 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 203 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 204 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206 FRANCE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 208 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 210 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 212 SPAIN : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 213 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 214 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 215 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 218 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 219 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 220 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 SPAIN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 222 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 223 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 224 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 227 ITALY : HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 230 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 232 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 233 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 234 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 235 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236 ITALY: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 238 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 239 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 240 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 241 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 242 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 243 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 244 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 245 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 248 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 249 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 250 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 251 NORDIC COUNTRIES: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 252 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 253 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 254 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 257 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 259 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 260 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 261 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 262 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 263 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 264 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266 REST OF EUROPE: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 268 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 269 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 270 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 271 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 272 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 273 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 275 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 276 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 279 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 280 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 281 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 282 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 283 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 284 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HARDWARE, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION, 2024–2031 (USD MILLION)
TABLE 288 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PURCHASING MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 289 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR INVENTORY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 290 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED, 2024–2031 (USD MILLION)
TABLE 291 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2024–2031 (USD MILLION)
TABLE 292 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MEDICAL DEVICES & EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
TABLE 293 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION)
TABLE 294 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 295 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR MANUFACTURERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR DISTRIBUTORS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297 JAPAN: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298 CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING, 2024–2031 (USD MILLION)
TABLE 299 CHINA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET FOR SOFTWARE, BY TYPE, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2025–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2023–2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET DURING FORECAST PERIOD
FIGURE 8 INCREASING DIGITALIZATION AND AUTOMATION OF HEALTHCARE SUPPLY CHAINS TO DRIVE MARKET GROWTH
FIGURE 9 PURCHASING MANAGEMENT ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
FIGURE 10 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 16 RECENT FUNDING OF PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 17 PATENT PUBLICATION TRENDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2015–2026
FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT PATENTS, 2015–2026
FIGURE 19 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2015–AUGUST 2026)
FIGURE 20 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING HEALTHCARE SUPPLY CHAIN MANAGEMENT
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 23 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2021–2025
FIGURE 26 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 27 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: BRAND/ PRODUCT COMPARATIVE ANALYSIS
FIGURE 28 EV/EBITDA OF KEY VENDORS
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 30 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY FOOTPRINT
FIGURE 32 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33 SAP SE: COMPANY SNAPSHOT
FIGURE 34 ORACLE: COMPANY SNAPSHOT
FIGURE 35 IBM: COMPANY SNAPSHOT
FIGURE 36 CARDINAL HEALTH: COMPANY SNAPSHOT
FIGURE 37 MANHATTAN ASSOCIATES: COMPANY SNAPSHOT
FIGURE 38 TECSYS: COMPANY SNAPSHOT
FIGURE 39 MCKESSON: COMPANY SNAPSHOT
FIGURE 40 MEDLINE: COMPANY SNAPSHOT
FIGURE 41 BLUE YONDER GROUP, INC.: COMPANY SNAPSHOT
FIGURE 42 WORKDAY, INC.: COMPANY SNAPSHOT
FIGURE 43 ARVATO SYSTEMS: COMPANY SNAPSHOT
FIGURE 44 CENCORA, INC.: COMPANY SNAPSHOT
FIGURE 45 RESEARCH DESIGN
FIGURE 46 PRIMARY SOURCES
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 49 BOTTOM-UP APPROACH
FIGURE 50 TOP-DOWN APPROACH
FIGURE 51 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 52 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: CAGR PROJECTION ANALYSIS
FIGURE 53 DATA TRIANGULATION METHODOLOGY
FIGURE 1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SEGMENTATION
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2025–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2023–2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET DURING FORECAST PERIOD
FIGURE 8 INCREASING DIGITALIZATION AND AUTOMATION OF HEALTHCARE SUPPLY CHAINS TO DRIVE MARKET GROWTH
FIGURE 9 PURCHASING MANAGEMENT ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
FIGURE 10 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 12 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 13 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: VALUE CHAIN ANALYSIS
FIGURE 14 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
FIGURE 15 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 16 RECENT FUNDING OF PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
FIGURE 17 PATENT PUBLICATION TRENDS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2015–2026
FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT PATENTS, 2015–2026
FIGURE 19 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATENTS (JANUARY 2015–AUGUST 2026)
FIGURE 20 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING HEALTHCARE SUPPLY CHAIN MANAGEMENT
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
FIGURE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 23 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SNAPSHOT
FIGURE 25 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, 2021–2025
FIGURE 26 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET SHARE ANALYSIS OF KEY PLAYERS (2025)
FIGURE 27 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: BRAND/ PRODUCT COMPARATIVE ANALYSIS
FIGURE 28 EV/EBITDA OF KEY VENDORS
FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 30 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY FOOTPRINT
FIGURE 32 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33 SAP SE: COMPANY SNAPSHOT
FIGURE 34 ORACLE: COMPANY SNAPSHOT
FIGURE 35 IBM: COMPANY SNAPSHOT
FIGURE 36 CARDINAL HEALTH: COMPANY SNAPSHOT
FIGURE 37 MANHATTAN ASSOCIATES: COMPANY SNAPSHOT
FIGURE 38 TECSYS: COMPANY SNAPSHOT
FIGURE 39 MCKESSON: COMPANY SNAPSHOT
FIGURE 40 MEDLINE: COMPANY SNAPSHOT
FIGURE 41 BLUE YONDER GROUP, INC.: COMPANY SNAPSHOT
FIGURE 42 WORKDAY, INC.: COMPANY SNAPSHOT
FIGURE 43 ARVATO SYSTEMS: COMPANY SNAPSHOT
FIGURE 44 CENCORA, INC.: COMPANY SNAPSHOT
FIGURE 45 RESEARCH DESIGN
FIGURE 46 PRIMARY SOURCES
FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 49 BOTTOM-UP APPROACH
FIGURE 50 TOP-DOWN APPROACH
FIGURE 51 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 52 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: CAGR PROJECTION ANALYSIS
FIGURE 53 DATA TRIANGULATION METHODOLOGY
More Publications
Healthcare IT Market by Products & Services (Healthcare Provider Solutions, Healthcare Payer Solutions, & HCIT Outsourcing Services), Components (Services, Software, Hardware), End-User (Hospitals, Pharmacies, Payers), & Region - Global Forecasts to 2027
US$ 4,890.00
January 2023
536 pages
Health Information Exchange (HIE) Market by Set Up Type (Public, Private),Implementation Model ( Federated, Hybrid), Type (Pull, Push), Application (Web Portal, Secure Messaging), Solution (Portal, Platform Centric), End User - Global Forecast to 2025
US$ 2,970.00
April 2021
194 pages
Clinical Informatics Market by Function (EHR, Clinical Workflow, PHM, Telehealth, CDSS, Diagnostic, Analytics), Therapeutic Area (Onco, Neuro, Cardio), Component (Software), Deployment (Cloud), End-user (Hospital, ASC), & Region - Global Forecast to 2030
US$ 2,970.00
January 2025
539 pages
Life Sciences & Analytical Reagents Market Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016)
US$ 3,390.00
June 2012
326 pages
